How could we reduce antifungal use in the intensive care unit?

doi:10.5495/wjcid.v5.i4.55

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5676)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

459

WORD

352

HTML

2467

Figures (1-2)

157

Sum=3435

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1010

Download

1231

Sum=2241

Nov 25, 2015 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Infectious Diseases

ISSN

2220-3176

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Infect Dis. Nov 25, 2015; 5(4): 55-58
Published online Nov 25, 2015. doi: 10.5495/wjcid.v5.i4.55

Open in New Tab Full Size Figure Download Figure

Figure 1 Pros and cons of empirical antifungal treatment.

Open in New Tab Full Size Figure Download Figure

Figure 2 Use of biomarkers to deescalate antifungal treatment. AFT: Antifungal treatment; D: Day.

Citation: Rouzé A, Jaffal K, Nseir S. How could we reduce antifungal use in the intensive care unit? World J Clin Infect Dis 2015; 5(4): 55-58
URL: https://www.wjgnet.com/2220-3176/full/v5/i4/55.htm
DOI: https://dx.doi.org/10.5495/wjcid.v5.i4.55